Distribution of second and third malignancies, by type and gender, among 3122 Dutch patients who were originally diagnosed with HL by age 50 during 1965 to 1995, survived ≥5 years, and were followed through 2012.1
Distribution of second and third malignancies, by type and gender, among 3122 Dutch patients who were originally diagnosed with HL by age 50 during 1965 to 1995, survived ≥5 years, and were followed through 2012.1
